Aaron Moss

Aaron Moss serves as the Executive Director of Pharmacokinetics and Pharmacodynamics at Avidity Biosciences, Inc. since February 2023. Previously, Aaron was the Senior Director and Head of Translational Science at Neoleukin Therapeutics, where responsibilities included developing preclinical and clinical strategies compliant with FDA Project Optimus, managing bioanalytical functions, and providing pharmacokinetic analysis. Aaron has held significant positions at Astellas Gene Therapies and Certara, focusing on pharmacometrics, modeling, and regulatory support. With a PhD in Pharmaceutics from the University of Washington and a BS in Biochemistry from Western Washington University, Aaron has extensive experience in translational and clinical pharmacology, especially in the areas of immuno-oncology and gene therapy.